Fact checked by Nick Blackmer Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, ...

Even lower doses of Ethambutol can Induce Optic Neuropathy, suggests a study published in the Cureus.The present study aims ...

ImmunoGenesis has initiated the first subject dosing in a multicentre Phase I/II trial of IMGS-101 (evofosfamide), the ...

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses ...

Eli Lilly said it has launched new doses of its obesity treatment drug and reduced its prices.

Immune-Onc Therapeutics has dosed the first subject in the Phase Ib/II trial of IO-108 plus Roche’s atezolizumab and ...

Eli Lilly and Company (NYSE: LLY) announced the launch of 7.5 mg and 10 mg Zepbound (tirzepatide) single-dose vials, ...

KAMPALA, UGANDA | THE INDEPENDENT | The Ministry of Health has flagged off the distribution of 2.278 million doses of malaria ...

Revelation Biosciences (REVB) announced dosing of the first patient in the PRIME, or PReconditioning IMmunostimulatory Evaluation, Phase 1b ...